Genocea's (GNCA) investigational new drug application to initiate a clinical study to evaluate its neoantigen-specific cell therapy candidate, GEN-011 in cancer patients gets FDA clearance.
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Repligen Corporation (RGEN).
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
, /PRNewswire/ -- The report has been added to offering.
Axsome (AXSM) concludes a favorable pre-NDA meeting with the FDA for AXS-07, which is developed as an acute treatment of migraine. The company is on course to file the NDA in Q4.
Sorrento (SRNE) signs agreement to acquire SmartPharm Therapeutics in exchange for its common stock worth up to $19.4 million.
These top-ranked stocks are likely to beat on their bottom line in the next releases.
Repligen Corp (NASDAQ:RGEN) traded in a range yesterday that spanned from a low of $147.31 to a high of $149.73. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...
Albireo (ALBO) discontinues development of elobixibat in fatty liver diseases, following failure to achieve proof-of-concept for key NASH measures except LDL-C levels in a phase II study.
Eiger BioPharmaceuticals (EIGR) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Top Ranked Momentum Stocks to Buy for August 13th
Zacks.com featured highlights include: YETI, JD.com, Repligen, Shopify and Noble Energy
These top-ranked stocks are likely to beat on bottom line in their next releases.
Repligen Corp (NASDAQ:RGEN) traded in a range yesterday that spanned from a low of $152.46 to a high of $159.70. Yesterday, the shares gained 5.6%, which took the trading range above the 3-day high of...
Repligen (RGEN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Albany, New York based Engineered...
Investors Wary of the Weekend Again as Cases Rise
LGND vs. RGEN: Which Stock Is the Better Value Option?
Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over...
Here we pick four stocks that score as buying opportunities, despite their loss of value in the past week, on the back of strong fundamentals, prospects and optimism over a speedy U.S. economy revival....